IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome - 02/10/14
Doi : 10.1016/j.jaci.2014.07.008
Katariina Hannula-Jouppi, MD, PhD, MBA a, b 
, Satu-Leena Laasanen, MD, PhD c, Hannele Heikkilä, MD, PhD a, Mirja Tuomiranta, MD, PhD d, Marja-Leena Tuomi, MD c, Sirpa Hilvo, MD e, Nicolas Kluger, MD a, Sirpa Kivirikko, MD, PhD f, Alain Hovnanian, MD, PhD g, h, i, Soili Mäkinen-Kiljunen, PhD e, Annamari Ranki, MD, PhD a
, Satu-Leena Laasanen, MD, PhD c, Hannele Heikkilä, MD, PhD a, Mirja Tuomiranta, MD, PhD d, Marja-Leena Tuomi, MD c, Sirpa Hilvo, MD e, Nicolas Kluger, MD a, Sirpa Kivirikko, MD, PhD f, Alain Hovnanian, MD, PhD g, h, i, Soili Mäkinen-Kiljunen, PhD e, Annamari Ranki, MD, PhD a a Department of Dermatology and Allergology, University of Helsinki and Skin and Allergy Hospital, Helsinki University Central Hospital (HUCH), Helsinki, Finland
b Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland
c Department of Dermatology, Tampere University Hospital, Tampere, Finland
d Department of Dermatology, Seinäjoki Central Hospital, Seinäjoki, Finland
e Department of Allergology, Skin and Allergy Hospital, HUCH, Helsinki, Finland
f Department of Clinical Genetics, HUCH, Helsinki, Finland
g INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Paris, France
h Paris Descartes University–Sorbonne Paris Cité, Imagine Institute, Paris, France
i Department of Genetics, Necker Hospital for Sick Children, Paris, France
| Supported by Helsinki University Hospital Research funds (grant no. TYH2013235). |
|
| Disclosure of potential conflict of interest: K. Hannula-Jouppi has been supported by Helsinki University Hospital Research Funds (grant no. TYH2013235), has received travel support from the Finnish Dermatology Society, and has received travel support from the Finnish Dermatology Society and Jannsen-Cilaq. N. Kluger has been supported by grant the Helsinki University Central Hospital Research Funds (grant no. TYH2013235). S. Mäkinen-Kiljunen has received consultancy fees, lecture fees, and travel support from Thermo Fisher Scientific. A. Ranki is a member of the Independent Data Monitoring Committee, Millennium Pharmaceuticals, and the ImmunoQure AG Advisory Board. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 134 - N° 4
P. 985-988 - octobre 2014 Retour au numéro
Article précédent
- Lessons in gene hunting: A RAG1 mutation presenting with agammaglobulinemia and absence of B cells
- Mona Hedayat, Michel J. Massaad, Yu Nee Lee, Mary Ellen Conley, Jordan S. Orange, Toshiro K. Ohsumi, Waleed Al-Herz, Luigi D. Notarangelo, Raif S. Geha, Janet Chou
- Invariant natural killer T cells in patients with common variable immunodeficiency
- Dominic Paquin-Proulx, Bianca A.N. Santos, Karina I. Carvalho, Myrthes Toledo-Barros, Ana Karolina B. Oliveira, Cristina M. Kokron, Jorge Kalil, Markus Moll, Esper G. Kallas, Johan K. Sandberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?